chlormezanone
Sign in to saveAlso known as chlormethazanone, Fenaprim®, Trancopa®, 2-(p-chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide, (+-)-chlormezanone, 2-(p-chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide, (+-)-Chlormezanone, Chlormezanonum
Chlormezanone (marketed under the brandname Trancopal or Fenaprim) is a drug used as an anxiolytic and a muscle relaxant.
Research
191 papers- Chlormezanone poisoning.British medical journal (Clinical research ed.) · 1983
- Hepatocellular and dermatological outcomes of chlormezanone.JPMA. The Journal of the Pakistan Medical Association · 2022
- Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Clinical reviews in allergy & immunology · 2018
- Chlormezanone plasma and blood levels in patients after single and repeated oral doses and after suicidal drug overdose.European journal of drug metabolism and pharmacokinetics · 1991
- Diclofenac sodium-chlormezanone poisoning.European journal of clinical pharmacology · 1984
via PubMed
~1 min read
Encyclopedic overview
3 sectionsContents
- Synthesis
- References
- Further reading
Chlormezanone (marketed under the brandname Trancopal or Fenaprim) is a drug used as an anxiolytic and a muscle relaxant.
Its use was discontinued in many countries in 1996 due to rare but serious cases of toxic epidermal necrolysis.
Excerpted from Wikipedia’s “chlormezanone” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0